Valuation: Mega Lifesciences

Market Cap 30.08B 892M 796M 735M 667M 1.25B 84.49B 1.27B 8.85B 3.49B 44.27B 3.35B 3.28B 140B P/E 2026 *
13.2x
P/E 2027 * 12.1x
Enterprise Value 25.46B 755M 674M 622M 565M 1.06B 71.52B 1.08B 7.49B 2.95B 37.47B 2.83B 2.77B 119B EV / Sales 2026 *
1.78x
EV / Sales 2027 * 1.64x
Free-Float
38.66%
Yield 2026 *
5.16%
Yield 2027 * 5.53%
1 day+2.99%
1 week+4.55%
Current month+2.22%
1 month-4.17%
3 months-9.80%
Current year+2.99%
1 week 32.5
Extreme 32.5
34.75
1 month 32.5
Extreme 32.5
35.75
Current year 31.5
Extreme 31.5
40
1 year 28.5
Extreme 28.5
40
3 years 24.3
Extreme 24.3
46
5 years 24.3
Extreme 24.3
56.5
10 years 17.9
Extreme 17.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 1987-12-31
Director of Finance/CFO 62 1996-12-31
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 62 1997-12-31
Director/Board Member 64 2012-12-31
Director/Board Member 73 2013-01-31
Date Insider Type Main position Quantity % Market Cap. Importance
4/29/25 Buy

Chief Executive Officer

100,000 0.0115%
4/28/25 Buy

Chief Executive Officer

50,000 0.0057%
4/28/25 Buy

Chief Executive Officer

150,000 0.0172%
Change 5-day change 1-year change 3-year change Capi.($)
+2.99%+4.55%+18.97%-21.59% 869M
+2.83%+4.40%+60.84%+123.50% 1,133B
+3.81%+5.66%+38.70%+74.91% 621B
+0.14%+0.63%+24.71%+95.03% 503B
+0.03%+3.27%+39.79%+64.06% 379B
-1.76%+1.41%+68.06%+43.41% 370B
+1.58%+2.37%+22.91%+51.98% 292B
+2.90%+2.22%+3.51%+24.45% 262B
+2.04%+3.05%+51.12%+60.42% 237B
+2.36%-0.11%+29.42%+102.04% 190B
Average +1.87%+2.43%+35.80%+61.82% 398.89B
Weighted average by Cap. +1.96%+2.59%+42.87%+82.71%

Financials

2026 *2027 *
Net sales 14.33B 425M 379M 350M 318M 596M 40.25B 606M 4.22B 1.66B 21.09B 1.6B 1.56B 66.81B 15.5B 460M 410M 378M 344M 645M 43.54B 655M 4.56B 1.8B 22.81B 1.73B 1.69B 72.26B
Net income 2.24B 66.52M 59.37M 54.77M 49.76M 93.36M 6.3B 94.79M 660M 260M 3.3B 250M 244M 10.46B 2.49B 73.72M 65.8M 60.7M 55.15M 103M 6.98B 105M 731M 288M 3.66B 277M 271M 11.59B
Net Debt -4.62B -137M -122M -113M -102M -192M -12.97B -195M -1.36B -535M -6.79B -514M -503M -21.52B -4.72B -140M -125M -115M -105M -196M -13.26B -199M -1.39B -547M -6.95B -525M -514M -22B
Projected Income Statement - Annual - Mega Lifesciences
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
26-10-22 THB 34.50 +2.99% 710,695
26-10-21 THB 33.50 +2.29% 1,105,473
26-10-20 THB 32.75 0.00% 853,411
26-10-19 THB 32.75 -0.76% 677,464
26-10-15 THB 33.00 +0.76% 893,356
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Mega Lifesciences
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
34.50THB
Average target price
42.71THB
Spread / Average Target
+23.81%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Mega Lifesciences
  1. Stock Market
  2. Stocks
  3. MEGA Stock